CrCest Study in Primary Mitochondrial Disease

Status Enrolling by invitation

Clinical Trial Summary

The purpose of this study is to perform a "muscle phenotyping" magnetic resonance imaging (MRI) assessment in patients receiving clinical care at the Children's Hospital of Philadelphia (CHOP) for mitochondrial disease that is either suspected (based on clinical presentation) or has a definite genetic diagnosis. The MRI assessment quantifies skeletal muscle oxidative phosphorylation (OXPHOS) capacity. Investigators hope that this study will contribute to our current knowledge of mitochondrial diseases and this study will help create a new diagnostic tool for use in both clinical care and in clinical trials.

Clinical Trial Description

This research study visit will occur on the same day as the participants clinically scheduled MRI. The clinically indicated and study-specific scanning time will not exceed 120 minutes. During the study visits: - A study team member will review inclusion and exclusion criteria with the participant - A study team member will review medical history review with the participant - A safety assessment will occur prior to study procedures - Study MRI scan - During which the participant will use an MRI-safe machine to stimulate exercise, similar to pressing a gas pedal If eligible participants return to CHOP for future clinical imaging, we will also request a study-specific MRI assessment. ;

Study Design

Related Conditions & MeSH terms

Mitochondrial Diseases

Clinical Trial Details

NCT number	NCT04734626
Study type	Observational
Source	Children's Hospital of Philadelphia
Contact
Status	Enrolling by invitation
Phase
Start date	May 25, 2021
Completion date	December 31, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03388528` - Low Residue Diet Study in Mitochondrial Disease	N/A
Completed	`NCT04378075` - A Study to Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy	Phase 2/Phase 3
Completed	`NCT03678740` - Diagnostic Odyssey Survey 2
Recruiting	`NCT06051448` - Promoting Resilience in Stress Management (PRISM) and Clinical-focused Narrative (CFN) Pilot in Adults With Primary Mitochondrial Disease (PMD).	Phase 1/Phase 2
Completed	`NCT02909400` - The KHENERGY Study	Phase 2
Completed	`NCT02398201` - A Study of Bezafibrate in Mitochondrial Myopathy	Phase 2
Completed	`NCT03857880` - Identification of New Candidate Genes in Patients With Mitochondrial Disease by High Resolution Chromosome Analysis on DNA Chip
Completed	`NCT04165239` - The KHENERGYZE Study	Phase 2
Completed	`NCT02284334` - Glycemic Index in Mitochondrial Disease
Recruiting	`NCT06080568` - Human Mitochondrial Stress-driven Obesity Resistance
Recruiting	`NCT06080581` - Mitochondrial Dysfunctions Driving Insulin Resistance
Recruiting	`NCT04802707` - Deoxynucleosides Pyrimidines as Treatment for Mitochondrial Depletion Syndrome	Phase 2
Completed	`NCT04580979` - Natural History Study of FDXR Mutation-related Mitochondriopathy
Completed	`NCT04594590` - Natural History Study of SLC25A46 Mutation-related Mitochondriopathy
Withdrawn	`NCT03866954` - Trial of Erythrocyte Encapsulated Thymidine Phosphorylase In Mitochondrial Neurogastrointestinal Encephalomyopathy	Phase 2
Recruiting	`NCT04113447` - Mitochondrial Donation: An 18 Month Outcome Study.
Completed	`NCT03832218` - Executive Function Disorders and Anxio-depressive Symptomatology in Children and Adolescents With Mitochondrial Pathologies	N/A
Terminated	`NCT02473445` - A Long-term Extension of Study RP103-MITO-001 (NCT02023866) to Assess Cysteamine Bitartrate Delayed-release Capsules (RP103) in Children With Inherited Mitochondrial Disease	Phase 2
Recruiting	`NCT05012358` - Genomic Profiling of Mitochondrial Disease - Imaging Analysis for Precise Mitochondrial Medicine
Recruiting	`NCT04920812` - MITOMICS : a Multi-OMICS Approach for the Diagnosis of Mitochondrial Diseases